Cancer treatment is getting a high-tech upgrade. Scientists are now looking at something called circulating tumor DNA (ctDNA) to see how well treatments are working, especially for a type of cancer known as large B-cell lymphoma (LBCL). This isn't just any DNA; it's the DNA that tumors shed into the
DLBCL is a type of blood cancer that can be tough to treat. It stands for diffuse large B-cell lymphoma. The introduction of CAR-T therapy has been a game-changer for patients with relapsed or refractory DLBCL. CAR-T therapy is a type of treatment that uses a patient's own immune cells to fight ca
In Uganda, people with diffuse large B-cell lymphoma (DLBCL) face a tougher fight than those in wealthier nations. The main reason is that they do not have the same access to treatments. One treatment that has shown to improve survival rates is a combination of rituximab and chemotherapy. Rituxim
Imagine if cancer treatments could be more like a guided missile, hitting only the bad guys while leaving healthy cells unharmed. That's the idea behind antibody-drug conjugates (ADCs), which are revolutionizing the way we fight certain cancers, including diffuse large B-cell lymphoma (DLBCL). An A
